Change in BME Extent | Follow-up Interval after PV | |||||
---|---|---|---|---|---|---|

0–3 mo | 3–6 mo | 6–12 mo | ||||

Decrease Mean VAS | Decrease Analgesic Use | Decrease Mean VAS | Decrease Analgesic Use | Decrease Mean VAS | Decrease Analgesic Use | |

Decrease in BME | 6.3 | 86% | 0.4% | 0% | 0.7% | 14% |

Similar BME | 6.0 | 67% | 0.2 | 15% | 0.1 | 4% |

Regression coefficient | 1.3 | 0.8 | 0.2 | 0.2 | 0.6 | 0.6 |

95% confidence interval | −4.4–1.7 | −2.0–0.5 | −1.0–0.7 | −0.9–0.8 | −1.8–0.5 | −1.8–0.5 |

BME absent | 6.3 | 89% | 0.2 | 14% | 0.2 | 5% |

BME present | 6.0 | 82% | 0.3 | 6% | 0.4 | 8% |

Regression coefficient | 0.2 | 0.5 | 0.1 | 0.02 | 0.1 | 0.1 |

95% Confidence interval | −1.9–2.2 | −1.3–0.4 | −0.9–0.07 | −0.9–0.8 | −1.1–0.9 | −1.1–0.9 |